Myncov1003 / Mynvax, Indian Institute of Science - LARVOL DELTA

Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines. (PubMed, ACS Nano) - "Immunization with these mosaic nanoparticles elicited cross-reactive neutralizing antibodies against SARS-CoV-1 and MERS-CoV pseudoviruses. Our proof-of-concept data demonstrate the versatility of the LS nanoparticle platform for antigen presentation, supporting the development of multivalent vaccine designs targeting diverse antigens and contributing to immunogen design strategies."

Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases